Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-22

Clinical Trial Update: The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating omega-3 polyunsaturated fatty acids in heart failure was terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Columbia University | Conditions: Heart Failure | Phase 3 | Status: TERMINATED | Results posted: 2016-04-22